Загрузка...
The Epithelial Barrier Model Shows That the Properties of VSL#3 Depend from Where it is Manufactured
BACKGROUND: VSL#3 has been extensively investigated and is currently recommended for the prevention and treatment of chronic pouchitis and ulcerative colitis. Nonetheless, in vitro and in vivo stud-ies have recently shown variability in the VSL#3 efficacy often attributed to the manufacturing proces...
Сохранить в:
| Опубликовано в: : | Endocr Metab Immune Disord Drug Targets |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Bentham Science Publishers
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6425067/ https://ncbi.nlm.nih.gov/pubmed/30360752 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/1871530318666181022164505 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|